In lab research, team halts NASH liver damage

17 febrero 2015

Scientists have developed a drug that stops fatty liver disease from causing inflammation and scarring. Doctors believe that up to 30 percent of the U.S. population may have fat accumulation in the liver, known as non-alcoholic fatty liver disease (NAFLD), that can lead to a range of damaging health consequences.